首页> 外文OA文献 >Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

【2h】

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

机译：Dapagliflozin与SitaGliptin对2型糖尿病患者心肌素危险因素的疗效：一项前瞻性，随机研究（多样性-CVR）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ayako Fuchigami; Fumika Shigiyama; Toru Kitazawa; Yosuke Okada; Takamasa Ichijo; Mariko Higa; Toru Hiyoshi; Ikuo Inoue; Kaoru Iso; Hidenori Yoshii; Takahisa Hirose; Naoki Kumashiro;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR) [J] . Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, Cardiovascular Diabetology . 2020,第1期

机译：Dapagliflozin与SitaGliptin对2型糖尿病患者心肌素危险因素的疗效：一项前瞻性，随机研究（多样性-CVR）
2. Rationale and design of study of dapagliflozin versus sitagliptin treatment efficacy on prevention of cardiovascular risk factors in type 2 diabetes patients: the DIVERSITY-CVR study [J] . Fumika Shigiyama, Naoki Kumashiro, Ayako Fuchigami, Cardiovascular Diabetology . 2018,第1期

机译：达格列净与西他列汀治疗2型糖尿病患者预防心血管危险因素的理论依据和研究设计：DIVERSITY-CVR研究
3. Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study) [J] . Koshizaka Masaya, Ishikawa Ko, Ishibashi Ryoichi, Diabetes, obesity & metabolism . 2019,第8期

机译：比较IPRAGLIFLOZIN对二甲双胍对用SITAGLIPTIN治疗的2型糖尿病患者内脏脂肪减少和代谢功能障碍的影响：一种预期，多期，开放标签，盲终点，随机对照研究（PRIME-V研究）
4. Determining Significant Risk Factors for Cardiovascular Complications of Patient with Type 2 Diabetes Mellitus and Hypertension Using Multi-Expert Multi-Criteria Decision Making [C] . Napa Rachata International Conference on Digital Arts, Media and Technology;ECTI Northern Section Conference on Electrical, Electronics, Computer and Telecommunications Engineering . 2021

机译：使用多专家多标准决策，确定2型糖尿病患者心血管并发症的显着危险因素及高血压
5. A randomized, open-label, intervention study to evaluate the effect of diet composition on weight gain in obese, type 2 diabetes patients receiving intensive insulin therapy. [D] . Villareal, Roland. 2008

机译：一项随机，开放标签，干预性研究，以评估饮食结构对接受强化胰岛素治疗的肥胖2型糖尿病患者体重增加的影响。
6. Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective randomized study (DIVERSITY-CVR) [O] . Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, 2020

机译：达格列净与西他列汀对日本2型糖尿病患者心脏代谢危险因素的疗效：一项前瞻性随机研究（DIVERSITY-CVR）
7. Rationale and design of study of dapagliflozin versus sitagliptin treatment efficacy on prevention of cardiovascular risk factors in type 2 diabetes patients: the DIVERSITY-CVR study [O] . Fumika Shigiyama, Naoki Kumashiro, Ayako Fuchigami, 2018

机译：Dapagliflozin与SitaGliptin治疗疗效研究2型糖尿病患者心血管危险因素的理由和设计效果：多样性-CVR研究

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

著录项

引文网络

相似文献

相关主题

期刊订阅